CRISPR-cas systems

Prokaryotes upgrade to adaptive immunity

Rodolphe Barrangou, Luciano A. Marraffini

Research output: Contribution to journalReview article

278 Citations (Scopus)

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR), and associated proteins (Cas) comprise the CRISPR-Cas system, which confers adaptive immunity against exogenic elements in many bacteria and most archaea. CRISPR-mediated immunization occurs through the uptake of DNA from invasive genetic elements such as plasmids and viruses, followed by its integration into CRISPR loci. These loci are subsequently transcribed and processed into small interfering RNAs that guide nucleases for specific cleavage of complementary sequences. Conceptually, CRISPR-Cas shares functional features with the mammalian adaptive immune system, while also exhibiting characteristics of Lamarckian evolution. Because immune markers spliced from exogenous agents are integrated iteratively in CRISPR loci, they constitute a genetic record of vaccination events and reflect environmental conditions and changes over time. Cas endonucleases, which can be reprogrammed by small guide RNAs have shown unprecedented potential and flexibility for genome editing and can be repurposed for numerous DNA targeting applications including transcriptional control.

Original languageEnglish (US)
Pages (from-to)234-244
Number of pages11
JournalMolecular cell
Volume54
Issue number2
DOIs
StatePublished - Apr 24 2014

Fingerprint

Clustered Regularly Interspaced Short Palindromic Repeats
Adaptive Immunity
Guide RNA
Endonucleases
DNA
Archaea
Ribonucleases
Small Interfering RNA
Immune System
Immunization
Vaccination
Plasmids
Biomarkers
Viruses
Bacteria

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cell Biology

Cite this

Barrangou, Rodolphe ; Marraffini, Luciano A. / CRISPR-cas systems : Prokaryotes upgrade to adaptive immunity. In: Molecular cell. 2014 ; Vol. 54, No. 2. pp. 234-244.
@article{6c668e5d2c8344dbb58778ec2f1da392,
title = "CRISPR-cas systems: Prokaryotes upgrade to adaptive immunity",
abstract = "Clustered regularly interspaced short palindromic repeats (CRISPR), and associated proteins (Cas) comprise the CRISPR-Cas system, which confers adaptive immunity against exogenic elements in many bacteria and most archaea. CRISPR-mediated immunization occurs through the uptake of DNA from invasive genetic elements such as plasmids and viruses, followed by its integration into CRISPR loci. These loci are subsequently transcribed and processed into small interfering RNAs that guide nucleases for specific cleavage of complementary sequences. Conceptually, CRISPR-Cas shares functional features with the mammalian adaptive immune system, while also exhibiting characteristics of Lamarckian evolution. Because immune markers spliced from exogenous agents are integrated iteratively in CRISPR loci, they constitute a genetic record of vaccination events and reflect environmental conditions and changes over time. Cas endonucleases, which can be reprogrammed by small guide RNAs have shown unprecedented potential and flexibility for genome editing and can be repurposed for numerous DNA targeting applications including transcriptional control.",
author = "Rodolphe Barrangou and Marraffini, {Luciano A.}",
year = "2014",
month = "4",
day = "24",
doi = "10.1016/j.molcel.2014.03.011",
language = "English (US)",
volume = "54",
pages = "234--244",
journal = "Molecular Cell",
issn = "1097-2765",
publisher = "Cell Press",
number = "2",

}

CRISPR-cas systems : Prokaryotes upgrade to adaptive immunity. / Barrangou, Rodolphe; Marraffini, Luciano A.

In: Molecular cell, Vol. 54, No. 2, 24.04.2014, p. 234-244.

Research output: Contribution to journalReview article

TY - JOUR

T1 - CRISPR-cas systems

T2 - Prokaryotes upgrade to adaptive immunity

AU - Barrangou, Rodolphe

AU - Marraffini, Luciano A.

PY - 2014/4/24

Y1 - 2014/4/24

N2 - Clustered regularly interspaced short palindromic repeats (CRISPR), and associated proteins (Cas) comprise the CRISPR-Cas system, which confers adaptive immunity against exogenic elements in many bacteria and most archaea. CRISPR-mediated immunization occurs through the uptake of DNA from invasive genetic elements such as plasmids and viruses, followed by its integration into CRISPR loci. These loci are subsequently transcribed and processed into small interfering RNAs that guide nucleases for specific cleavage of complementary sequences. Conceptually, CRISPR-Cas shares functional features with the mammalian adaptive immune system, while also exhibiting characteristics of Lamarckian evolution. Because immune markers spliced from exogenous agents are integrated iteratively in CRISPR loci, they constitute a genetic record of vaccination events and reflect environmental conditions and changes over time. Cas endonucleases, which can be reprogrammed by small guide RNAs have shown unprecedented potential and flexibility for genome editing and can be repurposed for numerous DNA targeting applications including transcriptional control.

AB - Clustered regularly interspaced short palindromic repeats (CRISPR), and associated proteins (Cas) comprise the CRISPR-Cas system, which confers adaptive immunity against exogenic elements in many bacteria and most archaea. CRISPR-mediated immunization occurs through the uptake of DNA from invasive genetic elements such as plasmids and viruses, followed by its integration into CRISPR loci. These loci are subsequently transcribed and processed into small interfering RNAs that guide nucleases for specific cleavage of complementary sequences. Conceptually, CRISPR-Cas shares functional features with the mammalian adaptive immune system, while also exhibiting characteristics of Lamarckian evolution. Because immune markers spliced from exogenous agents are integrated iteratively in CRISPR loci, they constitute a genetic record of vaccination events and reflect environmental conditions and changes over time. Cas endonucleases, which can be reprogrammed by small guide RNAs have shown unprecedented potential and flexibility for genome editing and can be repurposed for numerous DNA targeting applications including transcriptional control.

UR - http://www.scopus.com/inward/record.url?scp=84899134190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899134190&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2014.03.011

DO - 10.1016/j.molcel.2014.03.011

M3 - Review article

VL - 54

SP - 234

EP - 244

JO - Molecular Cell

JF - Molecular Cell

SN - 1097-2765

IS - 2

ER -